
ASH 2021 Conference Coverage on VuMedi
Video Player is loading.
Current Time 0:00
/
Duration 0:00
Loaded: 0%
0:00
Stream Type LIVE
Remaining Time -0:00
1x
- 0.5x
- 0.75x
- 1x, selected
- 1.25x
- 1.5x
- 1.75x
- 2x
- Chapters
- descriptions off, selected
- captions settings, opens captions settings dialog
- captions off, selected
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
10 seconds
Playback speed
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
ASH 2021 Rationale for and Results of a Phase I Study of the TGF-β 1/3 Inhibitor AVID200 in Subjects with MF
By
ASH 2021 Conference Coverage on VuMedi
FEATURING
John Mascarenhas
By
ASH 2021 Conference Coverage on VuMedi
FEATURING
John Mascarenhas
57 views
December 17, 2021
Comments 0
Login to view comments.
Click here to Login
MDS and MPN